MedTrace Logo

A Study of a Dietary Supplement in Breastfeeding Mothers (WellFed)

NCT05924633 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 57

Last updated 2024-09-19

No results posted yet for this study

Summary

This is a randomized placebo-controlled study that aims to investigate the effect of a new maternal dietary supplement (protein hydrolysate/yeast beta-glucan combination) on mother and infant health.

Conditions

  • Dietary Habits
  • Dietary Supplements
  • Maternal Health
  • Breastfeeding
  • Infant Health

Interventions

DIETARY_SUPPLEMENT

Supplement containing a protein hydrolysate + beta glucan (Wellmune®)

Supplement taken daily for 4 weeks.

DIETARY_SUPPLEMENT

Placebo supplement containing maltodextron

Placebo supplement taken daily for 4 weeks.

Sponsors & Collaborators

  • University College Dublin

    lead OTHER

Principal Investigators

  • Aifric O'Sullivan, PhD · University College Dublin

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
49 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-06-06
Primary Completion
2024-08-31
Completion
2024-08-31

Countries

  • Ireland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05924633 on ClinicalTrials.gov